Hepatitis B DNA vaccine - PowderMed

Drug Profile

Hepatitis B DNA vaccine - PowderMed

Alternative Names: Hepatitis B therapeutic vaccine - PowderMed; pdpSC 18; pPWRG 7128

Latest Information Update: 17 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PowderMed
  • Developer Pfizer
  • Class DNA vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Phase I Hepatitis B

Most Recent Events

  • 05 Feb 2008 Phase-I development is ongoing
  • 04 Apr 2006 Phase-I clinical trials in Hepatitis B treatment in Hong Kong (Intradermal)
  • 04 Apr 2006 Phase-I clinical trials in Hepatitis B treatment in Singapore (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top